Soya-derived textured vegetable protein is increasingly used as a protein substitute in Western diets. It also replaces more expensive proteins in the diets of young animals, especially calves. Although processing procedures have removed most of the known antinutritional constituents of soya,' the young calf is particularly sensitive to ingestion of certain soya proteins. A systemic, IgG-mediated, immune response to soya has been shown to induce physiological and morphological disturbances of intestinal function which may result in impaired growth performance. [2] [3] [4] [5] There is evidence that soya can cause a malabsorption syndrome in infants.6-9 Whether or not it can produce similar effects in normal adults is largely unknown, although feeding trials, in which conventional protein was replaced by soya, showed no significant change in the physiological parameters studied.10 Soya is also used in certain diets, for example gluten-free diets (GFD) 
Results
Antibody activity (mean ± SEM) to soya-derived protein in each of the groups studied is shown in Table 2 , and the number of individuals with significant antibody activity is summarised in Table 3 . Using monospecific antisera, the soya antibodies detectable by both the ELISA and immunofluorescent assays were found to be predominantly of IgG class: only the IgG antibody titres for these assays are therefore shown. In particular, no significant soya-specific IgE antibody activity was found. None of the sera from normal healthy adults had significant activities of IgG antibody to soya by Mean log2 haemagglutinating antibody titres to soya were significantly higher in patients with coeliac disease than in the control population (p < 0-05) and patients with inflammatory bowel disease (p < 0-05). Mean values in the "GFD-good responder" and "GFD-poor responder" coeliac subgroups were not significantly different.
Soya-specific IgG antibody detected by ELISA is shown in the Figure. The mean titre in the "GFDpoor responder" coeliac subgroup was significantly higher than in the "GFD-good responder" subgroup (p < 0-05), healthy controls (p < 0-05) patients with duodenitis (p < 0.05) or inflammatory bowel disease (p < 0-05).
Immunofluorescent studies on soya bean (Tables 2 and 3) showed that whereas very few of the healthy or patient control sera demonstrated significant fluorescence beyond the initial screening dilution of 1/8, three of the "GFD-good responder" coeliacs and six of the seven "GFD-poor responder" coeliacs had raised titres.
Finally, there was no correlation between titres of IgG-ELISA antibodies to different dietary antigens in either the seven "GFD-poor responder" coeliacs (Table 4) or the "GFD-good responder" subgroup (results not shown).
Discussion
Normal healthy persons had only low activities of antibody to soya in amounts that probably reflect no more than harmless exposure. On the other hand, significant anti-soya antibodies have been found more commonly in patients with coeliac disease, particularly in the "GFD-poor responder" subgroup, than in patients with other gastrointestinal diseases. This 
